Subject	Predicate	Object
Au3 Ligand	can perturb	host energy metabolism
Au3 Ligand	can perturb	immunity
microbiome	affect	human health
flora	represent	the kingdom Plantae therefor e
Microbiota	indicate	the microbial community
chronic lung diseases	can alter	composition
the Chinese	have	more diverse species
environmental and genetic factors	need	investigation
localized microbiome	can cause	far-reaching consequences
microbiota	can protect	physiological functions
a certain gut bacteria	cause	behavioral abnormality
the main fermentation products	provide	exte rnal resources
host parameters	could influence	the composition
host parameters	could influence	different consequences
co-colonization	promote	innate immune responses
Oral administration	improve	tumor-specific immunity
Bacteroides fragilis	protect	its host
Escherichia coli O21	protect	mice
interactions	can influence	health
Commensal microbes	determine	persistence
interferon-lambda	determine	persistence
Angiotensin-converting enzyme 2	link	amino acid malnutrition
dysbiosis	regulate	progression
Inflammation-associated enterotypes	drive	gut microbiota variation
host genotype	drive	gut microbiota variation
inter-individual effects	drive	gut microbiota variation
Inflammation-associated enterotypes	influence	the gut
Reciprocal gut microbiota transplants	reveal	host habitat selection
Caspase deficiency	alter	the murine gut microbiome
Human genetics	shape	the gut microbiome
Host genetic variation	influence	the upper airway microbiome
Complex host genetics	influence	the microbiome
MHC variation sculpts 	individualize	microbial communities
Chylomicrons	promote	intestinal absorption
Microbiota	modulate	behavioral and physiological abnormalities
Probiotic administration	attenuate	myocardial hypertrophy
Probiotic administration	attenuate	heart failure
Synbiotics	prevent	asthma
Bifidobacterium longum / Synergy	initiate	resolution
Commensal Bifidobacterium	promote	antitumor immunity
Metagenomic analyses	induce	pathogenic alterations
A microbial symbiosis factor	prevent	intestinal inflammatory disease
assessing the microbiota composition at high taxonomic resolution	reveal	changes
the microbiota	modulate	the function
the microbiota	modulate	homeostasis
evolution	favour	functional redundancy
truncal vagotomy	reduce	the risk
Methodical standardization procedures	ensure	the comparability
Enterococcus	unclassiﬁed	< Ruminococcaceae OTU
Ruminococcaceae	unclassiﬁed	< Ruminococcaceae OTU
Actinobacteria	show	an increase
PD patients	show	an increase
Three studies	find	a signiﬁcant reduction
Three studies	find	the genus Prevotella
One study	find	a similar but not signiﬁcant decrease
Verrucomicrobia	report	changes
Proteobacteria Single studies	find	changes
Entacapone	would not display	its beneﬁcial effects
A minority	discover	an aberrant Firmicutes
several other factors	inﬂuence	the Firmicutes : Bacteroides ratio
before extracting the DNA	increase	the Firmicutes : Bacteroides ratio
Commensal Clostridium species	show	a signiﬁcant and descriptive decrease
Two PD studies	show	an increase
The increased Ruminococcaceae	might play	in PD
Faecalibacterium , partly speciﬁed as Faecalibacterium prausnitzi or as an out	show	a signiﬁcant decrease
Faecalibacterium	show	a negative correlation
the Faecalibacterium prausnitzi species	include	a high diversity
Lachnospiraceae family	show	a depletion
Lachnospiraceae	include	many putative anti - inﬂammatory and thus potentially protective genera
Lachnospiraceae	include	potentially protective genera
The key members	show	a conﬁrmed decrease
Glucuronidase enzymes	mediate	the regeneration
Glucuronidase enzymes	activate	endogenous glucuronides
its metabolites	display	regulatory immune function
Glucuronidase enzymes	might penetrate	the mucus layer
BMAA	target	N - Methyl - D - aspartate ( NMDA ) receptors
BMAA	target	the neurotransmitter glutamate
Cyanobacteria	can produce	neurotoxins
PD patients	show	an increase in Cyanobacteria
AD patients	show	a decrease in Cyanobacteria
a probiotic intervention	could prevent	progression
the species Prevotella melaninogenica	show	an increase
Prevotella	exhibit	one of the highest effect sizes of change in the study of NMO
The fact	suggest	a possible protective role
Akkermansia muciniphila	exert	beneﬁcial effect
Akkermansia	use	mucus
Akkermansia together with Eubacterium , Capnocytophaga , Phascolarctobacterium and OTUs no further classiﬁed than to Firmicutes	achieve	a high prediction score
Escherichia coli , a member of the Enterobacteriaceae family ,	show	translocation
that Enterobacteriaceae ( and C . perfringens , B . fragilis , and Pseudomonas )	produce	hydrogen water
Pseudomonas	produce	hydrogen water
These researchers	perform	a study
Heintz - Buschart	discover	depleted unclassiﬁed OTUs
that	exhibit	very low fractional abundance
the genome	encode	an endoglucanase
All unclassiﬁed OTUs	show	common features
no studies	have analyse	the gut microbiome
this disease	show	a high conversion rate
Only one human case control study	analyse	the colonic microbiome
that	include	a decreased Firmicutes phylum
that	include	Clostridium genus
AD	show	an increased Bacteroidetes phylum
that	might evolve	discriminative power
Inheriting	increase	Christensenellaceae
Microbes	tickle	your tummy
Microbes	inﬂuence	neurologic disease
Dextrins	inhibit	the growth
Freezing fecal samples prior to dna extraction	affect	the ﬁrmicutes
Aquaporin 4 - speciﬁc t cells	exhibit	a th17 bias
Clostridium	perfringen	epsilon toxin
Clostridium perfringens epsilon toxin	induce	permanent neuronal degeneration
Clostridium perfringens epsilon toxin	induce	behavioral changes
Live faecalibacterium prausnitzii	does not enhance	epithelial barrier integrity
Human genetics	shape	the gut microbiome
The human gut	harbor	non - photosynthetic bacte ria
groundwater	harbor	non - photosynthetic bacte ria
Fecal microbiota transplantation therapy	mediate	the progression
Colonic FMT group	show	signiﬁcant improvement
Colonic FMT group	show	longer maintenance
FMT	can relieve	the motor and non - motor symptoms
PD	constitute	a serious public health burden
Colonic FMT	show	longer maintenance
PD treatment drugs	include	Madopar
PD treatment drugs	include	Trastal
PD treatment drugs	include	Amantadine
PD treatment drugs	include	Pramipexole
PD treatment drugs	include	Entacapone
PD treatment drugs	include	Peribedil
PD treatment drugs	include	Selegiline
PD treatment drugs	include	Rasagiline
Colonic FMT	show	longer maintenance
FMT	improve	the patients
FMT	improve	anxiety
only the colonic FMT group	show	the improvement effect
The damaged intestinal barrier	cause	systemic inﬂammation
Gut microbiota	may regulate	neuroinﬂammation
gut microbiota metabolites	may regulate	neuroinﬂammation
FMT	change	the gut microbiota
FMT	change	gut microbiota metabolites
the microbiota transplantation route	may affect	the efﬁcacy
colonoscopic FMT	show	better therapeutic effect
The fecal microbiota	represent	the colonic microbiota
nasointestinal FMT	has not achieve	satisfactory results
FMT	can relieve	the motor and non-motor symptoms
pathology	involve	both the enteric and the central nervous system
pathology	involve	the central nervous system
The gastrointestinal microbiome	encompass	a vast diversity
L-DOPA-naïve PD patients	carry	an altered gut microbiota composition
medication	affect	bacteria
in which medication affects bacteria and bacteria in turn	affect	the disease
PD samples	form	a subgroup
Gut microbes	discriminate	PD participants
PD patients	exhibit	significantly greater intestinal permeability
the early , L-DOPA-naïve PD patients	hold	a different species pattern
SCFA administration	promote	motor dysfunction
SCFA administration	promote	α-syn-mediated neuro-inflammation
The gut bacteria	harbor	a diverse phageome
Urinary metabolomics	demonstrate	significant changes
catabolism	include	glucuronidation
Pathological alpha - synuclein transmission	initiate	Parkinson-like neurodegeneration
Extracellular vesicles	protect	the progression
Commensal Akkermansia muciniphila exacerbates	gut	inflammation
Diet	alter	the human gut microbiome
Neuroinflammation	potentiate	each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease
alpha-synuclein dysfunction	potentiate	each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease
Short-chain fatty acids	regulate	the enteric neurons
Short-chain fatty acids	regulate	gastrointestinal motility
Gut microbiota	regulate	motor deficits
Gut microbiota	regulate	neuroinflammation
FMT	could raise	the a - diversity of Proteobacteria and Bacteroidetes
gut microbiota	can regulate	brain neurochemistry
Fecal microbiota transplantation	cure	epilepsy
Short-term daily intake	does not shorten	intestinal transit time
Fecal microbiota transplantation	induce	remission
the microbiome	inﬂuence	pathogenesis
FMT	impair	spatial learning
FMT	impair	memory
AD FMT	reduce	Verrucomicrobia
AD FMT	reduce	Proteobacteria
FMT-AD-HP	improve	behavioral measures
FMT-AD-HP	improve	decreased neuroinﬂammation
with constipation	consider	one of the earliest markers of prodromal PD [ 53 ]
FMT	restore	the abundance
FMT	increase	striatal neurotransmitters
FMT	increase	regulatory T-cells
FMT	ameliorate	the symptoms
FMT	restore	proportion
GI	had enrich	Hungatella hathewayi
D	espite	these limitations
Elangovan	publish	their manuscript
Borody	publish	their manuscript
Holsinger	publish	their manuscript
Conﬂicts	declare	no conﬂict
The authors	declare	no conﬂict
the microbiome	inﬂuence	anxiety
the microbiome	inﬂuence	depression
Altered microbiomes	distinguish	Alzheimer’s disease
Fecal microbiota transplantation	alleviate	Alzheimer ’ s disease - like pathogenesis
Fecal microbiota transplantation	decrease	amyloid load
Gut microbiota	enable	spontaneous autoimmune encephalomyelitis
Gut bacteria	modulate	human T cells
Fecal Microbiota Transplantation	reduce	Pathology and Improves Cognition
Butyrate - producing microbes	rescue	the deﬁcit mitochondrial respiration
Butyrate - producing microbes	rescue	ATP synthesis
Butyrate - producing microbes	rescue	autophagy
microbiota - synthesized micronutrients	exhibit	beneﬁcial value
Gut microbiome	regulate	the bile acids production
Gut microbiome	regulate	glucose metabolism
Gut microbiome	regulate	potentially hepatic autophagy
Secondary bile acids	possess	antimicrobial
Phenolic derivatives	repress	pathogenic microbes
rAntimicrobial effects	repress	pathogenic microbes
rUrolithin	exhibit	anti - inﬂammatory and cancer chemopreventive effects
spermidine	enhance	cancer development
spermine rDysregulated polyamine metabolism	enhance	cancer development
rSpermine	inhibit	pro - inﬂammatory M1 macrophage activation
Disrupted gut barrier function	will increase	gut permeability
microbial derived products	dysregulate	T - cell response
gut microbiota	facilitate	maturation
gut microbiota	facilitate	lymphocytopoiesis
EGCs	form	the enteric glial network
host factors	can induce	dysbiosis
secondary bile acids	inhibit	vegetative growth
Antibiotic administration	perturb	the gut microbial communities
scindens	inhibit	outgrowth
Colon biopsy samples	show	reduced mucus layer
Colon biopsy samples	show	defective epithelium
Colon biopsy samples	show	deep microbe
Colon biopsy samples	show	leukocyte - inﬁltration
the impaired host antimicrobial defense	reduce	the initial suppression
they	observe	a signiﬁcant elevation
Decrease	could enable	outgrowth
IBD	involve	heightened host inﬂammatory response
current therapeutic approaches for IBD	target	the aberrant pro - inﬂammatory immune response
Celiac disease	cause	cytoskeleton rearrangement
Celiac disease	cause	reduced occludin – ZO - 1 protein – protein interaction
Gram - negative bacteria	exhibit	secretion systems
Biﬁdobacterium lactis	exert	inhibitory on the increased gut permeability induced by gliadin
Prebiotics such as inulin - type fructans that selectively nourish Roseburia and Clostridium cluster XIVa , and arabinoxylan that increases the abundance of Biﬁdobacterium , Roseburia , and Bacteroides ,	have demonstrate	anti - adipogenic
arabinoxylan	have demonstrate	anti - adipogenic
tumor outgrowth	would damage	the intestinal barrier
gut microbiome	display	a bidirectional self - feeding relationship
CRC	display	a bidirectional self - feeding relationship
colonization	can trigger	TH17 - dependent colon tumorigenesis
BFT - mediated loss	could activate	T - cell factor – dependent Wnt ( Wingless - Int ) / β - catenin nuclear signaling in intestinal ep ithelial cells
combined action	can induce	myeloid into pro - tumoral monocytic - myeloid - derived suppressor cells ( MO - MDSCs )
that	could promote	vascular endothelial growth factor ( VEGF ) - mediated tumor angiogenesis
Biﬁdobacterium	could facilitate	PD - L1 blockade
treating the gastrointestinal dysfunction	will alleviate	such ASD - associated symptoms
treatment	has demonstrate	beneﬁcial in alleviating ASD - like symptoms in murine model
probiotic Biﬁdobacterium infantis	improve	the behavioral abnormalities
probiotic Biﬁdobacterium infantis	improve	stress - associated gastrointestinal dysfunction
Gut microbial products	regulate	murine gastrointestinal motility
Metabolic endotoxemia	initiate	obesity
Metabolic endotoxemia	initiate	insulin resistance
Dietary ﬁbre - based SCFA mixtures	promote	both protection
Dietary ﬁbre - based SCFA mixtures	promote	repair
Systematic information	improve	adherence
Microbiota - generated metabolites	promote	metabolic beneﬁts
The microbiome	regulate	energy metabolism
butyrate	regulate	energy metabolism
Vitamin D deﬁciency	change	the intestinal microbiome
Metabolism	link	bacterial bioﬁlms
Metabolism	link	colon carcinogenesis
Microbiota	control	the homeostasis
Intestinal microbiota metabolism	promote	atherosclerosis
Biﬁdobacterium longum	modulate	immune responses
Urolithins	exhibit	estrogenic and antiestrogenic activities
Human originated bacteria	produce	conjugated linoleic acid
Dysbiosis	may trigger	autoimmune diseases
Biﬁdobacterium strains	suppress	the pro - inﬂammatory milieu
T4 phage tail adhesin gp12	counteract	LPS - induced inﬂammation
the blood – brain barrier dysfunction	induce	b y activated microglia
Fusobacterium nucleatum	promote	colorectal carcinogenesis
Biﬁdobacterium longum	inhibit	colon cancer
Commensal Biﬁdobacterium	promote	antitumor immunity
Corticotropin - releasing hormone	stimulate	thermogenesis
Chronic kidney disease	alter	intestinal microbial ﬂora
Symbiotic bacterial metabolites	regulate	gastrointestinal barrier function
Gut ﬂora metabolism	promote	cardiovascular disease
Metabolomics analysis	reveal	large of gut microﬂora on mammalian blood metabolites
Bacteroides fragilis enterotoxin	induce	c - Myc expression
Bacteroides fragilis enterotoxin	induce	cellular proliferation
A human colonic commensal	promote	colon tumorigenesis
Fusobacterium nucleatum	potentiate	intestinal tumorigenesis
Short - chain fatty acids	stimulate	leptin production
probiotic supplementation	improve	intestinal microbial balance
probiotic supplementation	improve	immunity
probiotic supplementation	improve	overall g rowth
probiotic supplementation	increase	the microbial diversity
probiotic supplementation	increase	richness
Taxonomic composition comparison	determine	operational taxonomic units
Transcriptome analysis	produce	RNA - seq reads
probiotic supplementation	increase	the microbial diversity
probiotic supplementation	increase	richness
plantarum in nursery pig diets	increase	growth performance
plantarum in nursery pig diets	increase	blood immunoglobulin concentrations
plantarum complex	elevate	the fecal population
size	affect	the absorption capacity
the gut microbiota	undergo	dramatic and partly revocable alterations
The ratio	can affect	the capacity
The relative abundance	occupy	the largest part
their incre	ase	abundance
The study	administrate	L
rhamnosus GG	did not detect	the statistical difference
we	perform	the enumeration
we	predict	the expression pattern
We	perform	gene ontology analysis
which	constitute	a diverse family
The gene expression analysis	identify	PLA2G2A
BPI	play	a significant function
SLPI	inhibit	several leukocyte serine proteases
transcriptome data	present	probiotic suppl ementation
These gene expression data	imply	attenuated inflammation status
Two - component signaling cascade	affect	flagellar rotation
chemotaxis - related proteins	affect	flagellar rotation
probiotic supplemenation	increase	branched chain amino acid biosynthesis
probiotic supplemenation	increase	butyrate metabolism
Branched chain amino acids	promote	intestinal development
Branched chain amino acids	promote	maintenance
Branched chain amino acids	promote	immune defense functions
Oral treatment	reduce	Brachyspira pilosicoli - induced pathology
Diet	shape	the gut microbiome
Lactobacillus	promote	intestinal development
plantarum PFM	promote	intestinal development
Probiotic Lactobacillus rhamnosus GG	induce	alterations
Interleukin - 22 - induced antimicro - bial phospholipase A2 group IIA	mediate	protective innate immunity
gut bacteria	play	important roles
Important bacterial PAMP ligands	comprise	lipopolysaccharides
Important bacterial PAMP ligands	comprise	peptidoglycans
Important bacterial PAMP ligands	comprise	lip - oteichoic acid
Important bacterial PAMP ligands	comprise	ﬂagellin
Important bacterial PAMP ligands	comprise	muramyldipeptide
Microbiota metabolites	affect	host metabolism
SCFAs	trigger	the secretion
, butyrate	activate	b - oxidation
, butyrate	activate	oxidative phosphorylation
intratumoral expression	can inhibit	tumor growth
copri	show	beneﬁcial effects
recent study	show	that P . copri and Bacteroides vulgatus exacerbate glucose tolerance
whether P . copri works as a beneﬁcial or deleterious bacterium	require	further investigation
Bacteroides	fragili	Anti - inﬂammations
muciniphila	modulate	the endocannabinoid ( eCB ) system
A . muciniphila	may involve	anticancer immunotherapy
muciniphila	improve	the compromised efﬁcacy
muciniphila	show	many beneﬁcial effects
fragilis strains	involve	the abdominal infections
fragilis strains	show	many beneﬁcial effects
fragilis polysaccharide A	direct	microbiota
fragilis polysaccharide A	direct	host interactions
goldsteinii als	show	its potential
a water extract	reduce	obesity
a water extract	reduce	inﬂammation
a water extract	reduce	resistance
a water extract	reduce	insulin
A high molecular weight polysaccharide fraction	lower	body weight
g oldsteinii bacteria	reduce	weight gain
g oldsteinii bacteria	reduce	obesity - associated metabolic disorders
Subclinical - dose endotoxin	sustain	low - grade inﬂammation
Ganoderma lucidum	reduce	obesity
Butyrate	enhance	the intestinal barrier
Microbiota - activated PPAR - gamma signaling	inhibit	dysbiotic Enterobacteriaceae expansion
Commensal Biﬁdobacterium	promote	antitumor immunity
Human gut microbes	impact	host serum metabolome
Human gut microbes	impact	insulin sensitivity
The human commensal Bacteroides fragilis	bind	intestinal mucin
Plasmacytoid dendritic cells	mediate	anti - inﬂammatory responses
Human genetics	shape	the gut microbiome
Eubacterium limosum ameliorates	attenuate	colonic inﬂammatory action
experimental colitis	attenuate	colonic inﬂammatory action
Enterococcus hirae	facilitate	cyclophosphamide - induced therapeutic immunomodulatory effects
barnesiella	facilitate	cyclophosphamide - induced therapeutic immunomodulatory effects
intestinihominis	facilitate	cyclophosphamide - induced therapeutic immunomodulatory effects
intestinal lumen microflora	influence	CRC risk
mucosa - associated microbiota	affect	CRC risk
The highly enriched major Gram - negative bacteria	exhibit	direct interaction
enriched Fusobacteria	infect	intestinal tissue
Synergistetes	infect	intestinal tissue
Mucosa adherent microbial structures	exhibit	similarity
the swab microflora	represent	a combination
the swab microflora	represent	a mucosa population
the segmented filamentous bacteria	induce	inflammation
prausnitzii	induce	colonization resistance
Faecalibacterium	play	a probiotic role
R . gnavus	produce	an antibacterial peptide
gingivalis	penetrate	periodontal tissue
the enriched bacteria Desulfovibrio	reduce	sulfate
intestinal lumen microflora	influence	CRC risk
Fusobacterium nucleatum	could cause	colorectal cancer
an infection	could cause	colorectal cancer
reducing inflammation	promote	engraftment of the healthy donor microbiota
a higher Simpson dominance	mean	a higher concentration
A subgroup	reach	a successful combined clinical and endo scopic remission
our analyses	highlight	a potentially beneficial role
we	identify	several other bacterial families
which	exhibit	associations
those who received FMT from donor	require	stronger micro biota changes
Prevotellaceae	constitute	a sizable proportion
Screening the patients ( and donors ) for Prevotellaceae before and during treatment and matching donors to patients	might improve	the response
higher levels of Prevotellaceae	may confer	health benefits
the intestinal microbiota	exhibit	complex interactions
Mucosa - associated gut microbiota	reflect	clinical course
Perturbation	enhance	host susceptibility
Cultivation - independent genomes	expand	taxonomic - profiling capabilities
Fecal microbiota transplantation	induce	remission
Kae	can attenuate	lipopolysaccharide ( LPS ) - induced murine neuroinﬂammation
Kae	can suppress	LPS / ATP - induced inﬂammatory responses
Kae supplementation	improve	the intestinal barrier
DSS treatment	cause	severe enteric mucosal injury
Kae	could alleviate	the gross symptoms
Kae	attenuate	DSS - Triggered Pro - Inﬂammatory Responses
DSS	trigger	signiﬁcantly increased serum IL
DSS	trigger	TNF - a levels
Kae supplementation	reverse	this tendency
DSS treatment	increase	mRNA level expression
Kae pre - treatment	reveal	an improvement
the anti - inﬂammation effects	involve	maintenance
Kae	reshape	the Diversity
Kae	reshape	Richness
DSS	trigger	metabolic endotoxemia
Kae pretreatment	inhibit	DSS - induced expression
FMT	increase	colon length
FMT	increase	reduced DAI scores
Kae	increase	the diversity
Kae	increase	richness
Kae	could alleviate	epithelial barrier dysfunction
Kae supplementation	alleviate	UC
The major phyla constituting	include	Firmicutes
The major phyla constituting	include	Bacteroides
intestinal microorganisms	include	Firmicutes
intestinal microorganisms	include	Bacteroides
Kae	could reverse	the F / B ratio
Kae	suppress	the LPS - TLR4 - NF - kB signaling pathway
Kae	reduce	the intestinal permeability
Kae	could restore	the expression
Kae	exert	immunoregulatory effects
Kae	exert	excellent anti - UC effects
Kae	reduce	LPS levels
Kaempferol	inhibit	the Invasion
Kaempferol	inhibit	Migration
Non - Soya Legume - Based Therapeutic Lifestyle Change Diet	reduce	Inﬂammatory Status
Dietary Kaempferol 	suppresses	Inﬂammation
this act in part by causing the accumulation of misfolded proteins , in addition to producing other deleterious model	remain	the gold standard
mutations	cause	an inherited vulnerability
through the oral administration	alleviate	most of Clinical Characteristics of PD these symptoms
dopamine antagonists	occur	fre - Hydrocephalus : normal pressure hydrocephalus
depletors Hemiatrophy - hemiparkinsonism Abnormalities	occur	fre - Hydrocephalus : normal pressure hydrocephalus
they	project	Progressive supranucle ar palsy
putamenal DA	is deplete	80 %
most PD patients	suffer	considerable motor disability
Bradykinesia	may impair	the minals
Immunostaining	reveal	a Lewy body
some patients	develop	to the onset
Human epidemiological studies	have implicate	resi - dence
quaternary ammonium cation	prevent	its passage
some environmental factors	do modify	PD susceptibility
Pathogenic mutations	may induce	abnormal protein conformations
misfolded proteins	cause	toxicity
misfolded proteins	cause	damage cells
Lewy bodies	promote	toxicity
LBs	contain	oxidatively modified - synuclein
Several herbicides	induce	misfolding
pesticides	induce	misfolding
long thought to play a cumulation of misfolded proteins	may provoke	a vicious cycle
MPTP	block	the mitochondrial electron
PCD	occur	the mitochondrial respiration
that	display	fea - normally produced as byproducts , including hydrogen tures of apoptosis , a morphological correlate of PCD
oxidation	produce	DA - quinone
DA - quinone	damage	proteins
sporadic and inherited PD , or posed differently	does take	many decades
inherited PD	does take	many decades
Presumably , all of these tox - cell - based ( e . g . , stem cell ) or pharmacological thera - ins	provoke	the formation
pharmacological thera - ins	provoke	the formation
6 - OHDA	produce	a more protracted eration
gene therapy	mimic	the motor symptoms ways
These re - minergic neurons	share	key molecular features
rotenone	exert	a more widespread PD
dopaminergic neurons	display	The herbicide paraquat ( N , N - dimethyl - 4 - 4 - bipiridi - sensitivity
As noted above , In addition , the use of rotenone in rodents is technically paraquat	show	structural similarity
paraquat	does penetrate	the blood
its CNS distribu - relationship	does not parallel	any known enzymatic or neuroana - death
the an irreversible and severe parkinsonian syndrome char - investigators	find	clear evidence
Rote - exhibit preferential degeneration of putamenal versus none	bind	mitochondrial complex
dopa - rotenone	may enter	all cells
Neuromelanin	may contribute	neurodegenera
the pro - toxin trophic factor ( GDNF ) both	limit	MPTP - MPTP
the pro - toxin trophic factor ( GDNF ) both	limit	the only cells
deletion	prevent	MPTP - induced do - kinsonism
heterozy - gous V MAT2 null mice	display	enhanced sensitivity
MPP effects	can stimulate	the production
that heterozy - gous V MAT2 null mice display enhanced sensitivity to chondria	can stimulate	the production
critical effectors	impair	oxidative phosphorylation
mitochondrial release	demonstrate	that the activation of PCD is instru - c ( an electron carrier and a mediator of PCD ) , and activa - mental in MPTP toxicity
mitochondrial release	demonstrate	activa - mental
MPTP administra - formation	will help	focus research
some atypical features	have been note	PD
some atypical features	involve	protein aggregation
this prevalent presynap - tic protein	may modulate	synaptic vesicle function
( re - known pathogenic - synuclein mutations	promote	the for - mation
presynaptic nerve terminals	may cause	toxicity
parkin mutant patients	display	the classical signs
none	assess	dopaminergic nerve terminal striking response
Parkin	contain	two RING the protein
Parkin	contain	an ubiquitin - like that membrane binding elicits a functionally important alteration in the protein
membrane binding	elicit	a functionally important alteration
ligase	may be traffic	proteins
E3	ligase	confer target specificity
the dria	has been implicate	E3 ligase activity
dopaminergic neurodegen - neurons parkin overexpression	attenuate	cyclin E ac - eration
This minergic neurons	catalyze	the hydrolysis
UCH - L1	exert	a previously unrecognized ubi - quitin ligase activity
transgenic coexpression	prevent	the dopaminergic neuronal loss
dysfunction	reproduce	features
Paraquat	elicit	neurobehavior al syndrome tance
Neurology	preserve	dopamine neurons
Neurology	preserve	motor function
Mutation Systemic administration	produce	selective damage
Oxi - dative damage	induce	NADH - depen - synuclein nitration
1 - Mehtyl - 4 - phenylpyridinium	induce	NADH - depen - synuclein nitration
meperidine analogue N - methyl - 4 - phenyl - 1 , 2 , 3 , 6 - tetrahydropyridine Chronic systemic complex I inhibition	induce	a hypokinetic on brain catecholamine neurons in the mouse
transporters	accelerate	dopamine - induced apoptosis
6 - hydroxydo - 53 →Thr mutation	cause	neurodegenerative disease
Mutations	cause	autosomal recessive juvenile
The neurotoxin 1 - methyl - 4 - phenylpyridinium is Dopamine neurons from transgenic mice with a knockout of the p53 gene	resist	MPTP neurotoxicity
Dopamine	transporter	me ssenger RNA
heterozygotes	display	reduced amphetamine - con - Vila
DJ	regulate	the androgen receptor
Increased Caspase	accompany	nuclear GAPDH translocation
Increased Caspase	accompany	neuronal apoptosis Warrick
immunoreactivity	accompany	nuclear GAPDH translocation
immunoreactivity	accompany	neuronal apoptosis Warrick
NADPH oxidase	mediate	oxidative stress
Gene transfer	protect	dopaminergic neurons
Probiotics	can confer	health beneﬁts
live microorganisms	can confer	health beneﬁts
The phylum Firmicutes	include	Gram - positive bacteria
the phylum Bacteroidetes	include	approximately 7000 species
dysbiotic increases	do not change	the F / B ratio
probiotics	can treat	several diseases
Changes	can cause	obesity
Changes	can cause	inﬂammatory bowel disease
Speciﬁc probiotics	can restore	the gut microbial balance
The gut microbiota	promote	bile acid metabolism
The gut microbiota	promote	modiﬁes hepatic triglyceride
The gut microbiota	promote	glucose homeostasis
Qatari subjects	exhibit	altered gut microbiota
( BMI < 25 kg / m2 ) Korean adolescents ( aged 13 – 16 years )	reveal	no significant differences
rhamnosus hsryfm	decrease	Firmicutes
Enhanced insulin sensitivity	decrease	low - density lipoprotein cholesterol
The administration of Lactobacillus rhamnosus GG and Lactobacillus sakei NR28	decrease	the F / B ratio
the two probiotic strains	reduce	epididymal fat mass
the two probiotic strains	reduce	stearoyl - CoA desaturase
rhamnosus hsryfm	reduce	serum lipid levels
A 12 - week high - fat diet	induce	an obese insulin - resistant condition
salivarius Ls - 33	increase	the Bacteroidetes – Prevotella – Porphyromonas – Firmicutes ratio
Apart from Lactobacillus , bacteria from the genus Bacillus , namely Bacillus amyloliquefaciens SC06 ,	decrease	the F / B ratio
Apart from Lactobacillus , bacteria from the genus Bacillus , namely Bacillus amyloliquefaciens SC06 ,	decrease	body weight
Apart from Lactobacillus , bacteria from the genus Bacillus , namely Bacillus amyloliquefaciens SC06 ,	decrease	hepatic steatosis
IBD	encompass	two types
UC	cause	long - lasting inﬂammation
CD	cause	inﬂammation
TNF - α	play	a pivotal role
Gut microbiota	can induce	inﬂammatory reactions
TLRs	maintain	gut homoeostasis
The TLR heterodimers	triacylate	lipopeptides
certain TLRs	play	a protective role
TLR - 9	recognize	bacterial CpG DNA
Gut microbiota metabolites	can protect	the host
SCFAs	increase	extrathymic regulatory T cell
SCFAs	promote	the synthesis
prausnitzii	demonstrate	anti - inﬂammatory
prausnitzii	reduce	the severity
A fecal microbial analysis	reveal	decreased abundancies
Bacteroidetes bacteria	exhibit	pro - inﬂammatory properties
Firmicutes bacteria	exhibit	anti - inﬂammatory
biﬁdum WBIN03	increase	unidentiﬁed Firmicutes
Increased antioxidant factors	decrease	TNF - α
[ 85 ] L . fermentum KBL374 and L . fermentum KBL375 Increased Lactobacillus	decrease	Bacteroides
[ 85 ] L . fermentum KBL374 and L . fermentum KBL375 Increased Lactobacillus	decrease	Mucispirillium
reuteri DSM	affect	gut microbial homeostasis
The probiotic gavage	increase	the proportion
reuteri DSM	support	trafficking of regulatory T cells
Both live and heat - killed bacteria	increase	Firmicutes
The probiotic	exert	an ti - inflammatory effects
The combination	reduce	UC
The probiotic mixture	increase	the abundance
the two probiotics	downregulate	TNF - α and
the two probiotics	downregulate	upregulated antioxidant factors
fermentum KBL374 and L . fermentum	correct	gut dysbiosis
IBD patients	receive	a probiotic yogurt
biﬁdobacteria - fermented milk	reduce	the relative proportion
Biﬁdobacteria	alter	gut microbiota
the F / B ratio	can reduce	weight gain
The gut microbiota	suppress	insulin - mediated fat accumulation
Obesity	alter	the microbial community proﬁle
Lactobacillus paracasei HII01	reduce	gut disturbance
xylooligosaccharides	reduce	gut disturbance
synbiotics	reduce	gut disturbance
Saccharomyces boulardii administration	changes	gut microbiota
Microbiota - dependent crosstalk	promote	intestinal homeostasis
Metabolites	promote	peripheral regulatory T - cell generation
Microbiota - derived short - chain fatty acids	promote	Th1 cell IL - 10 production
High - throughput clone library analysis	reveal	dysbiosis between inﬂamed and non - inﬂamed regions
Commensal Bacteroides species	induce	colitis
Lactobacillus reuteri DSM 17938 feeding	regulate	immune responses
Lactobacillus plantarum AN1 cells	increase	caecal L
Lactobacillus fermentum species	ameliorate	dextran sulfate sodium - induced colitis
Butyrylated starch	increase	colonic butyrate concentration
Consumption	increase	Faecalibacterium prausnitzii abundance
the duodenum	harbor	most of the phyla and groups , including the duodenum - unique Chlorobi , Chloroflexi , Ni trospirae , SM2F11 , SPAM , TM6 and WS3 groups
Bacteroidia	dominate	the GI t ract
Three bacterial phyla	dominate	the GI tract
Bacteroidetes	dominate	the GI tract
the Proteobacteria	dominate	the GI tract
Bacteriodetes	dominate	the WT mice gut
the gastric and small intestinal microbiota	show	remarkable inter - mouse variation
The variable dominance	support	the influence
the mouse GI tract	harbor	many distinct niches
Equine stomachs	harbor	an abundant and diverse mucosal microbiota
Rest tremor	are consider	the cardinal signs of PD
Other clinical features of PD	include	secondary motor symptoms
genetic mutations	increase	oxidative stress
Rest tremor	can involve	the lips
Rest tremor	can involve	chin
Rest tremor	can involve	jaw
Rest tremor	can involve	legs
Taking more than two steps backwards or the absence of any postural response	indicate	an abnormal postural response
movements	accompany	voluntary activity
Features of PD	include	orthostatic hypotension
Features of PD	include	sweating dysfunction
Features of PD	include	93 sphincter dysfunction
Features of PD	include	erectile dysfunction
Rapid eye movement sleep behaviour disorder	consider	a pre - parkinsonian state
Recent positron emission tomography imaging studies	have show	relative preservation
Brain parenchyma sonography	discriminate	Parkinson ’ s disease
Brain parenchyma sonography	discriminate	atypical parkinsonian syndromes
the induced Th17 cells	potentiate	inflammatory disease
copri	enhance	susceptibility
PhyloPhlAn	locate	400 u biquitous bacterial genes
Prevotella OTU4	form	a clade
TU12	form	a clade
OTU934	form	a clade
we	apply	MetaPhlAn
MetaPhlAn	determine	the presence
MetaPhlAn	determine	absence
ubiquinone oxidoreductase	figure	supplement 2A
the NORA metagenome	encode	unique functions
copri	reveal	the ability
copri - colonized mice	had reduce	Bacteroidales
copri - colonized mice	had reduce	Lachnospiraceae
copri colonized mice	show	significantly decreased weight loss
an environmental factor	trigger	systemic joint inflammation
dysbiosis	influence	human RA
the ubiquinone oxidoreductase pathway	may provide	a fitness advantage
copri	dominate	the colonic m icrobiome
copri	recapitulate	the differences
copri	may facilitate	resistance
copri genome	encode	phosphoadenosine phosphosulfate reductase
copri	display	increased inflammation
copri - defined microbiota thrives	may exacerbate	inflammation
NLRP6 inflammasome	regulate	colonic microbial ecology
Intestinal microbiota metabolism	promote	atherosclerosis
SILVA	align	ribosomal RNA sequence data
The genome	reveal	extensive auxotrophy
The genome	reveal	adaptations
Genome - wide association studies	have identify	multiple loci
Genome - wide association studies	have identify	heritable bacterial taxa
Genome - wide association studies	have identify	single nucleotide polymorphisms
the low GRS group	present	high abundance
Prevotellaceae	show	the highest importance
macronutrient intake	modify	the association
Host genetics	determine	the metabolism
Host genetics	determine	absorption
bacteria	produce	a wide range
several investi gations	have show	sex - related differences
Human genetics	shape	the gut microbiome
Genome - wide association analysis	identify	variation
Symbiotic gut microbes	modulate	human metabolic phenotypes
Body mass index	affect	diverse microbial niches
sex	affect	diverse microbial niches
Previous studies	have demonstrate	constipation in PD patients
Previous studies	have demonstrate	infrequent bowel movements in PD patients
constipation	affect	the PD patient ’
The intesti - nal immune system	play	an essential role
gut microbiota	affect	the motor symptom s
SCFA	modulate	the activity
fecal microbiota transplantation	exacerbate	the α - Syn mediated motor dysfunction
gut microbiota	can influence	brain function
bacteria	can produce	SCFA
Gut microbiota	regulate	motor deficits
Gut microbiota	regulate	neuroin ‑ flammation
Gastrointestinal transit time	use	a mag netic tracking system
Host microbiota	control	maturation
Host microbiota	control	function
Microbiota Transfer Therapy	alter	gut ecosy stem
Short - chain fatty acids	regulate	the enteric neurons
Short - chain fatty acids	regulate	control
Short - chain fatty acids	regulate	gastrointestinal motility
H22954	inhibit	cancer growth
Movement disorder specialists	administer	the UPDRS
Movement disorder specialists	administer	MDS - UPDRS
study coordinators	administer	the UPDRS
study coordinators	administer	MDS - UPDRS
The MDS - UPDRS	show	high internal consis - tency
midline function	leave	upper extremity
midline function	leave	postural and kinetic tremors
bradykinesia	leave	upper extremity
bradykinesia	leave	postural and kinetic tremors
The MDS - UPDRS	involve	participation
the composition	reﬂect	an effort
We	place	special emphasis
we	did not achieve	our goal
The clinimetric analysis	support	the reliability
The clinimetric analysis	support	validity
The scaling modiﬁcations	provide	new information
item addi - tions	provide	new information
that	represent	clinically relevant domains
it	allow	statistical assessment
the two scales	are measure	the same overall entity
The ﬁnal step	will involve	an assessment
avail - able statistical pro grams	will allow	this level
one	endorse	a high score
the other	endorse	a high score
the two curves	do not follow	a linear progression
the item	does not perform	the same
we	present	the MDS - UPDRS
The MDS Task Force	has initiate	a number
we	recommend	a uniform selection
The next steps	include	the non - English translations
Acknowledgments	receive	unrestricted grants
The MDS	receive	unrestricted grants
The UK Parkinson ’ s	provide	sup - port
Disease Society	provide	sup - port
We	acknowledge	the work
the MDS	acknowledge	the work
whose data	form	the core
We	observe	intestinal barrier injury
We	observe	gut
microbiota dysbiosis	coccaceae	genus enrichment
Fecal microbiota transplantation	mirror	the effect
macrophage depletion	attenuate	BMS - 1 - induced cardiotoxicity
neutralization	attenuate	BMS - 1 - induced cardiotoxicity
Prevotella loescheii recolonization	alleviate	PD - 1
butyrate supplementation	alleviate	PD - 1
Butyrate	can protect	against doxorubicin ( DOX ) - induced cardiotoxicity
its derivative phenylalanine butyramide	can protect	against doxorubicin ( DOX ) - induced cardiotoxicity
manipu - lation	prevent	PD - 1 / PD - L1 inhibitor - induced cardio - myocyte apoptosis and cardiotoxicity
manipu - lation	prevent	cardiotoxicity
its metabolites	prevent	PD - 1 / PD - L1 inhibitor - induced cardio - myocyte apoptosis and cardiotoxicity
its metabolites	prevent	cardiotoxicity
a PD - 1 inhib - itor	induce	cardiac injury
flavonoid glabridin	prevent	DOX - induced acute cardiotoxicity
CYP4X1 inhibition	repolarize	tumor - asso - ciated macrophages
small - mol - ecule PD - 1 / PD - L1 inhibitors	offer	inherent advantages
gut microbiota dysb iosis	upregulate	proinflam - matory factors
gut microbiota dysbiosis	promote	M1 - like polarization
gut microbiota dysbiosis	promote	the production
Intestinal barrier dysfunction	amplify	PD - 1 / PD - L1 inhibitor - related cardiotoxicity
targeting gut microbiota to polarize colonic mac rophages away from the M1 - like phenotype	could provide	a potential therapeutic strategy
The food intake by the mice treated with the PD - 1 / PD - L1 inhibitor BMS - 1 ( 5 and 10 mg / kg )	show	a decreasing trend compare d
BMS	decrease	the weight
BMS	increase	the BNP level
BMS	increase	interstitial fibrosis and the number of terminal deoxynucleotidyl transferase dUTP nick end labeling ( TUNEL ) - positive cardiomyo - cytes in the cardiac tissues
the PD - 1 / PD - L1 inhibitor BMS - 1	induce	cardiomyocyte apoptosis
the PD - 1 / PD - L1 inhibitor BMS - 1	induce	car diotoxicity
BMS ‑	induce	intestinal mucosal barrier injury
BMS	decrease	the mesenteric perfusion
BMS	induce	intestinal mucosal barrier injury
BMS	did not influence	the total fecal bacterial load
BMS	did not influence	category
BMS	alter	the abundance
BMS - 1 dose	deplete	Bacteroidales
BMS - 1 dose	deplete	Christensenellales
loescheii colonization	alleviate	PD - 1 / PD - L1 inhibitor - related cardiotoxicity
butyrate supplementation	alleviate	PD - 1 / PD - L1 inhibitor - related cardiotoxicity
FMT	induce	the apoptosis
Gut microbiota metabolites	mediate	anti - inflammatory effects
BMS	decrease	butyrate level
loescheii colonization	attenuate	BMS - 1 - induced myocardial enzyme leakage
butyrate supplementation	attenuate	BMS - 1 - induced myocardial enzyme leakage
a PD - 1 inhibitor	induce	M1 - like polarization
the anti - IL - 1β	abolish	BMS - 1 - induced cardiotoxicity
anti - TNF - α antibody	abolish	BMS - 1 - induced cardiotoxicity
loescheii colonization	downregulate	IL ‑ 1β
loescheii colonization	downregulate	TNF ‑
butyrate supplementation	downregulate	IL ‑ 1β
butyrate supplementation	downregulate	TNF ‑
loescheii colonization	inhibit	the BMS - 1 - induced increase
butyrate supplementation	inhibit	the BMS - 1 - induced increase
loe scheii colonization	downregulate	the mRNA expression
butyrate supplementation	downregulate	the mRNA expression
loescheii colonization	prevent	M1 - like polarization
butyrate supplementation	prevent	M1 - like polarization
Butyrate	prevent	NF ‑ κB ‑ mediated M1 ‑
PPARα	regulate	M1 macrophage polarization
7C - F , butyrate	prevent	LPS - induced upregulation
loescheii colonization	downregulate	IL - 1β
loescheii colonization	downregulate	TNF - α
butyrate supplementation	downregulate	IL - 1β
butyrate supplementation	downregulate	TNF - α
7 Butyrate	prevent	NF - κB - mediated M1 - like polarization and cardiomyocyte apoptosis
the PPARα antagonist GW6471	abolish	the protective effect
that butyrate	prevent	LPS - induced M1 - like polarization and cardiomyocyte apoptosis
anti - IL - 1β	abolish	LPS - induced car - diotoxicity
anti - TNF - α antibody	abolish	LPS - induced car - diotoxicity
butyrate	prevent	NF - κB - mediated M1 - like polarization and cardiomyocyte apoptosis
PPARα	activate	human CYP4X1 gene transcrip - tion
PPARα siRNA	downregulate	CYP4X1
PPARα siRNA	downregulate	S2
PD - 1 / PD - L1 inhibitors	induce	cardiomyocyte apop - tosis
PD - 1 / PD - L1 inhibitors	induce	cardiotoxicity
loescheii colonization	play	a protective role
butyrate supplementation	play	a protective role
8 Butyrate	prevent	NF - κB - mediated M1 - like polarization and cardiomyocyte apoptosis
a PD - 1 / PD - L1 inhibitor	induce	car - diomyocyte apoptosis
a PD - 1 / PD - L1 inhibitor	induce	a nd cardiotoxicity
P . loescheii recolonization and butyrate supplementa - tion	decrease	the tumor weight
P . loescheii recolonization and butyrate supplementa - tion	decrease	luciferase intensity
loescheii	could influence	the efficacy
loescheii	could influence	cardiotoxicity
butyrate	could influence	the efficacy
butyrate	could influence	cardiotoxicity
Colonic macrophages	provide	an active target
TNF - α blockade	attenuate	PD - 1 / PD - L1 inhibitor - related cardiotoxicity
microbiota dysbiosis	mediate	PD - 1 / PD - L1 inhibitor - related cardiotoxicity
PPARα activation	upregulate	human CYP4X1 gene transcription
PPARα activation	upregulate	CYP4X1 - derived cannabinoid metabolites further activated PPARα
Cyp4x1 knockout	inhibit	PPARα expression
exogenous sup - plementation	promote	PPARα expression
inactivation	upregulate	proinflammatory factors IL - 1β
inactivation	upregulate	TNF - α
programmed cell death - ligand 1 interaction	protect	human cardiomyocytes
Glabridin	prevent	dox - orubicin - induced cardiotoxicity t hrough gut microbiota modulation
Glabridin	prevent	colonic macrophage polarization
CYP4X1 inhibition	normalize	glioma vasculature
KALRN mutations	promote	antitumor immunity
KALRN mutations	promote	immunotherapy response
Sequential blockade	cause	fulminant cardiotoxicity
PD - L1	cause	fulminant cardiotoxicity
PPARalpha - UGT axis activation	repress	intestinal FXR - FGF1 5 feedback signalling
N - oxide	protect	mito - chondrial energy metabolism
N - oxide	protect	cardiac functionality
Intestina l microbiome analyses	identify	melanoma patients
A proinflammatory gut microbiota	increase	systemic inflammation
A proinflammatory gut microbiota	increase	accelerates atherosclerosis
gut microbiota	affect	the brain activity
the brain activity	increase	intestinal permeability
intestinal permeability	increase	oxidative stress
oxidative stress	increase	local inflammation
local inflammation	cause	blood brain barrier leakage
dysfunction	accompany	PD
21 The most promising poten tial clinical pro dromal PD biomarkers	include	bowel dysfunction
21 The most promising poten tial clinical pro dromal PD biomarkers	include	mood disorders
gut microbiota	affect	the brain activity
Clinical biomarkers NMS	post	prandial fullness
Clinical biomarkers NMS	post	tremor NMS
pylori infection	fail	defecation attempts
small intestinal bacterial overgrowth Motor severity	fail	defecation attempts
, serum antigen test Constip ation and defecatory dysfunction Infrequent bowel movements	fail	defecation attempts
defecatory dysfunction Infrequent bowel movements	fail	defecation attempts
SIBO	affect	almost one quarter
SIBO	affect	its eradication results
neurons	can not control	reactive oxy gen species
neurons	can not control	reactive nitrogen species
glial cells	can not control	reactive oxy gen species
glial cells	can not control	reactive nitrogen species
systemic inflammation	promote	neuro inflammation
synuclein pathology	promote	neuro inflammation
neuro inflammation	characterize	PD
Gut inflammation	drive	gastrointestinal dysfunction mediated Parkinson ’ s disease ( PD ) pathogenesis model
Reliable Early Non - motor Biomarkers PD patients	exhibit	GI dysfunction
constipation	indicate	the development of PD
PD patients	show	inflammation
PD patients	show	oxidative stress
Objective measures for PD	include	leukocyte subset counts
Objective measures for PD	include	TNF - α
An increase IL - 6 concentration	collect	four years earlier predicts PD in pati ents
Gut microbiota	may regulate	5 - HT
5 - HT	enable	lipopolysaccharide translocation
117 Correlating Gastrointestinal Mediated Non - motor Symptoms	include	GI symptoms
117 Correlating Gastrointestinal Mediated Non - motor Symptoms	include	altered intestinal barrier function
117 Correlating Gastrointestinal Mediated Non - motor Symptoms	include	inflammation
117 Correlating Gastrointestinal Mediated Non - motor Symptoms	include	SIBO
These functional or behavioral tests	include	olfaction acuity test
These functional or behavioral tests	include	RBD screen ing questionnaire
These functional or behavioral tests	include	key board tapping test
These functional or behavioral tests	include	the bradykinesia akinesia incoordination test
These functional or behavioral tests	include	acceler ometer based examinations
auerbach ’ s plexuses in cases staged for PD	related	brain pathology
Alpha - synuclein	show	internal organ pathol ogy
Alpha - synuclein	show	autonomic deficits
Short - chain fatty acids	regulate	the e nteric neurons and control gastrointestinal motility